nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—Mouth ulceration—Doxorubicin—uterine cancer	0.00152	0.00152	CcSEcCtD
Gatifloxacin—Diabetes mellitus—Epirubicin—uterine cancer	0.00152	0.00152	CcSEcCtD
Gatifloxacin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00151	0.00151	CcSEcCtD
Gatifloxacin—Photosensitivity—Epirubicin—uterine cancer	0.0015	0.0015	CcSEcCtD
Gatifloxacin—Dizziness—Progesterone—uterine cancer	0.00149	0.00149	CcSEcCtD
Gatifloxacin—Hypertonia—Doxorubicin—uterine cancer	0.00147	0.00147	CcSEcCtD
Gatifloxacin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00147	0.00147	CcSEcCtD
Gatifloxacin—Abnormal vision—Doxorubicin—uterine cancer	0.00147	0.00147	CcSEcCtD
Gatifloxacin—Eye pain—Epirubicin—uterine cancer	0.00146	0.00146	CcSEcCtD
Gatifloxacin—Chills—Etoposide—uterine cancer	0.00146	0.00146	CcSEcCtD
Gatifloxacin—Mental disability—Doxorubicin—uterine cancer	0.00146	0.00146	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00146	0.00146	CcSEcCtD
Gatifloxacin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00145	0.00145	CcSEcCtD
Gatifloxacin—Vomiting—Progesterone—uterine cancer	0.00144	0.00144	CcSEcCtD
Gatifloxacin—Lymphadenopathy—Doxorubicin—uterine cancer	0.00143	0.00143	CcSEcCtD
Gatifloxacin—Renal failure acute—Epirubicin—uterine cancer	0.00143	0.00143	CcSEcCtD
Gatifloxacin—Rash—Progesterone—uterine cancer	0.00143	0.00143	CcSEcCtD
Gatifloxacin—Dermatitis—Progesterone—uterine cancer	0.00142	0.00142	CcSEcCtD
Gatifloxacin—Headache—Progesterone—uterine cancer	0.00142	0.00142	CcSEcCtD
Gatifloxacin—Diabetes mellitus—Doxorubicin—uterine cancer	0.0014	0.0014	CcSEcCtD
Gatifloxacin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.0014	0.0014	CcSEcCtD
Gatifloxacin—Photosensitivity—Doxorubicin—uterine cancer	0.00139	0.00139	CcSEcCtD
Gatifloxacin—Decreased appetite—Dactinomycin—uterine cancer	0.00139	0.00139	CcSEcCtD
Gatifloxacin—Dysgeusia—Etoposide—uterine cancer	0.00139	0.00139	CcSEcCtD
Gatifloxacin—Renal impairment—Epirubicin—uterine cancer	0.00139	0.00139	CcSEcCtD
Gatifloxacin—Dermatitis bullous—Epirubicin—uterine cancer	0.00138	0.00138	CcSEcCtD
Gatifloxacin—Back pain—Etoposide—uterine cancer	0.00137	0.00137	CcSEcCtD
Gatifloxacin—Muscle spasms—Etoposide—uterine cancer	0.00136	0.00136	CcSEcCtD
Gatifloxacin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00135	CcSEcCtD
Gatifloxacin—Eye pain—Doxorubicin—uterine cancer	0.00135	0.00135	CcSEcCtD
Gatifloxacin—Hypoglycaemia—Epirubicin—uterine cancer	0.00135	0.00135	CcSEcCtD
Gatifloxacin—Nausea—Progesterone—uterine cancer	0.00134	0.00134	CcSEcCtD
Gatifloxacin—Renal failure acute—Doxorubicin—uterine cancer	0.00132	0.00132	CcSEcCtD
Gatifloxacin—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.00132	0.00132	CcSEcCtD
Gatifloxacin—Feeling abnormal—Dactinomycin—uterine cancer	0.00132	0.00132	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00131	0.00131	CcSEcCtD
Gatifloxacin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.0013	0.0013	CcSEcCtD
Gatifloxacin—Migraine—Epirubicin—uterine cancer	0.0013	0.0013	CcSEcCtD
Gatifloxacin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00129	0.00129	CcSEcCtD
Gatifloxacin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00129	0.00129	CcSEcCtD
Gatifloxacin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.00128	CcSEcCtD
Gatifloxacin—Renal impairment—Doxorubicin—uterine cancer	0.00128	0.00128	CcSEcCtD
Gatifloxacin—Dermatitis bullous—Doxorubicin—uterine cancer	0.00128	0.00128	CcSEcCtD
Gatifloxacin—Face oedema—Epirubicin—uterine cancer	0.00127	0.00127	CcSEcCtD
Gatifloxacin—Vertigo—Etoposide—uterine cancer	0.00127	0.00127	CcSEcCtD
Gatifloxacin—Abdominal pain—Dactinomycin—uterine cancer	0.00126	0.00126	CcSEcCtD
Gatifloxacin—Body temperature increased—Dactinomycin—uterine cancer	0.00126	0.00126	CcSEcCtD
Gatifloxacin—Hypoglycaemia—Doxorubicin—uterine cancer	0.00125	0.00125	CcSEcCtD
Gatifloxacin—Loss of consciousness—Etoposide—uterine cancer	0.00125	0.00125	CcSEcCtD
Gatifloxacin—Ataxia—Epirubicin—uterine cancer	0.00124	0.00124	CcSEcCtD
Gatifloxacin—Convulsion—Etoposide—uterine cancer	0.00123	0.00123	CcSEcCtD
Gatifloxacin—Hypertension—Etoposide—uterine cancer	0.00122	0.00122	CcSEcCtD
Gatifloxacin—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.00122	0.00122	CcSEcCtD
Gatifloxacin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00122	0.00122	CcSEcCtD
Gatifloxacin—Dry skin—Epirubicin—uterine cancer	0.00121	0.00121	CcSEcCtD
Gatifloxacin—Chest pain—Etoposide—uterine cancer	0.00121	0.00121	CcSEcCtD
Gatifloxacin—Migraine—Doxorubicin—uterine cancer	0.0012	0.0012	CcSEcCtD
Gatifloxacin—Nasopharyngitis—Epirubicin—uterine cancer	0.00118	0.00118	CcSEcCtD
Gatifloxacin—Face oedema—Doxorubicin—uterine cancer	0.00118	0.00118	CcSEcCtD
Gatifloxacin—Hypersensitivity—Dactinomycin—uterine cancer	0.00118	0.00118	CcSEcCtD
Gatifloxacin—Gastritis—Epirubicin—uterine cancer	0.00117	0.00117	CcSEcCtD
Gatifloxacin—Confusional state—Etoposide—uterine cancer	0.00117	0.00117	CcSEcCtD
Gatifloxacin—Muscular weakness—Epirubicin—uterine cancer	0.00116	0.00116	CcSEcCtD
Gatifloxacin—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.00116	0.00116	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Etoposide—uterine cancer	0.00116	0.00116	CcSEcCtD
Gatifloxacin—Infection—Etoposide—uterine cancer	0.00115	0.00115	CcSEcCtD
Gatifloxacin—Ataxia—Doxorubicin—uterine cancer	0.00115	0.00115	CcSEcCtD
Gatifloxacin—Asthenia—Dactinomycin—uterine cancer	0.00115	0.00115	CcSEcCtD
Gatifloxacin—Asthma—Epirubicin—uterine cancer	0.00114	0.00114	CcSEcCtD
Gatifloxacin—Dysphagia—Epirubicin—uterine cancer	0.00114	0.00114	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Etoposide—uterine cancer	0.00113	0.00113	CcSEcCtD
Gatifloxacin—Tachycardia—Etoposide—uterine cancer	0.00113	0.00113	CcSEcCtD
Gatifloxacin—Dry skin—Doxorubicin—uterine cancer	0.00112	0.00112	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Etoposide—uterine cancer	0.00112	0.00112	CcSEcCtD
Gatifloxacin—Pancreatitis—Epirubicin—uterine cancer	0.00112	0.00112	CcSEcCtD
Gatifloxacin—Anorexia—Etoposide—uterine cancer	0.0011	0.0011	CcSEcCtD
Gatifloxacin—Diarrhoea—Dactinomycin—uterine cancer	0.00109	0.00109	CcSEcCtD
Gatifloxacin—Nasopharyngitis—Doxorubicin—uterine cancer	0.00109	0.00109	CcSEcCtD
Gatifloxacin—Hypotension—Etoposide—uterine cancer	0.00108	0.00108	CcSEcCtD
Gatifloxacin—Gastritis—Doxorubicin—uterine cancer	0.00108	0.00108	CcSEcCtD
Gatifloxacin—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.00108	0.00108	CcSEcCtD
Gatifloxacin—Muscular weakness—Doxorubicin—uterine cancer	0.00108	0.00108	CcSEcCtD
Gatifloxacin—Dysuria—Epirubicin—uterine cancer	0.00107	0.00107	CcSEcCtD
Gatifloxacin—Neutropenia—Epirubicin—uterine cancer	0.00107	0.00107	CcSEcCtD
Gatifloxacin—Asthma—Doxorubicin—uterine cancer	0.00105	0.00105	CcSEcCtD
Gatifloxacin—Dysphagia—Doxorubicin—uterine cancer	0.00105	0.00105	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Epirubicin—uterine cancer	0.00104	0.00104	CcSEcCtD
Gatifloxacin—Paraesthesia—Etoposide—uterine cancer	0.00104	0.00104	CcSEcCtD
Gatifloxacin—Pancreatitis—Doxorubicin—uterine cancer	0.00103	0.00103	CcSEcCtD
Gatifloxacin—Dyspnoea—Etoposide—uterine cancer	0.00103	0.00103	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Epirubicin—uterine cancer	0.00103	0.00103	CcSEcCtD
Gatifloxacin—Somnolence—Etoposide—uterine cancer	0.00103	0.00103	CcSEcCtD
Gatifloxacin—Vomiting—Dactinomycin—uterine cancer	0.00102	0.00102	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.00101	0.00101	CcSEcCtD
Gatifloxacin—Rash—Dactinomycin—uterine cancer	0.00101	0.00101	CcSEcCtD
Gatifloxacin—Decreased appetite—Etoposide—uterine cancer	0.00101	0.00101	CcSEcCtD
Gatifloxacin—Stomatitis—Epirubicin—uterine cancer	0.000991	0.000991	CcSEcCtD
Gatifloxacin—Constipation—Etoposide—uterine cancer	0.000989	0.000989	CcSEcCtD
Gatifloxacin—Conjunctivitis—Epirubicin—uterine cancer	0.000988	0.000988	CcSEcCtD
Gatifloxacin—Dysuria—Doxorubicin—uterine cancer	0.000986	0.000986	CcSEcCtD
Gatifloxacin—Neutropenia—Doxorubicin—uterine cancer	0.000986	0.000986	CcSEcCtD
Gatifloxacin—Sweating—Epirubicin—uterine cancer	0.000974	0.000974	CcSEcCtD
Gatifloxacin—Haematuria—Epirubicin—uterine cancer	0.000969	0.000969	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000963	0.000963	CcSEcCtD
Gatifloxacin—Epistaxis—Epirubicin—uterine cancer	0.000959	0.000959	CcSEcCtD
Gatifloxacin—Feeling abnormal—Etoposide—uterine cancer	0.000953	0.000953	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Doxorubicin—uterine cancer	0.000951	0.000951	CcSEcCtD
Gatifloxacin—Nausea—Dactinomycin—uterine cancer	0.000949	0.000949	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Etoposide—uterine cancer	0.000946	0.000946	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000932	0.000932	CcSEcCtD
Gatifloxacin—Bradycardia—Epirubicin—uterine cancer	0.000929	0.000929	CcSEcCtD
Gatifloxacin—Urticaria—Etoposide—uterine cancer	0.000919	0.000919	CcSEcCtD
Gatifloxacin—Stomatitis—Doxorubicin—uterine cancer	0.000917	0.000917	CcSEcCtD
Gatifloxacin—Abdominal pain—Etoposide—uterine cancer	0.000914	0.000914	CcSEcCtD
Gatifloxacin—Body temperature increased—Etoposide—uterine cancer	0.000914	0.000914	CcSEcCtD
Gatifloxacin—Conjunctivitis—Doxorubicin—uterine cancer	0.000914	0.000914	CcSEcCtD
Gatifloxacin—Hepatitis—Epirubicin—uterine cancer	0.000912	0.000912	CcSEcCtD
Gatifloxacin—Pharyngitis—Epirubicin—uterine cancer	0.000905	0.000905	CcSEcCtD
Gatifloxacin—Sweating—Doxorubicin—uterine cancer	0.000901	0.000901	CcSEcCtD
Gatifloxacin—Oedema peripheral—Epirubicin—uterine cancer	0.000899	0.000899	CcSEcCtD
Gatifloxacin—Haematuria—Doxorubicin—uterine cancer	0.000897	0.000897	CcSEcCtD
Gatifloxacin—Epistaxis—Doxorubicin—uterine cancer	0.000887	0.000887	CcSEcCtD
Gatifloxacin—Visual impairment—Epirubicin—uterine cancer	0.000879	0.000879	CcSEcCtD
Gatifloxacin—Erythema multiforme—Epirubicin—uterine cancer	0.000863	0.000863	CcSEcCtD
Gatifloxacin—Bradycardia—Doxorubicin—uterine cancer	0.000859	0.000859	CcSEcCtD
Gatifloxacin—Eye disorder—Epirubicin—uterine cancer	0.000853	0.000853	CcSEcCtD
Gatifloxacin—Hypersensitivity—Etoposide—uterine cancer	0.000852	0.000852	CcSEcCtD
Gatifloxacin—Tinnitus—Epirubicin—uterine cancer	0.000851	0.000851	CcSEcCtD
Gatifloxacin—Hepatitis—Doxorubicin—uterine cancer	0.000844	0.000844	CcSEcCtD
Gatifloxacin—Pharyngitis—Doxorubicin—uterine cancer	0.000838	0.000838	CcSEcCtD
Gatifloxacin—Oedema peripheral—Doxorubicin—uterine cancer	0.000832	0.000832	CcSEcCtD
Gatifloxacin—Asthenia—Etoposide—uterine cancer	0.00083	0.00083	CcSEcCtD
Gatifloxacin—Chills—Epirubicin—uterine cancer	0.000819	0.000819	CcSEcCtD
Gatifloxacin—Pruritus—Etoposide—uterine cancer	0.000818	0.000818	CcSEcCtD
Gatifloxacin—Visual impairment—Doxorubicin—uterine cancer	0.000813	0.000813	CcSEcCtD
Gatifloxacin—Erythema multiforme—Doxorubicin—uterine cancer	0.000798	0.000798	CcSEcCtD
Gatifloxacin—Erythema—Epirubicin—uterine cancer	0.000794	0.000794	CcSEcCtD
Gatifloxacin—Diarrhoea—Etoposide—uterine cancer	0.000791	0.000791	CcSEcCtD
Gatifloxacin—Eye disorder—Doxorubicin—uterine cancer	0.000789	0.000789	CcSEcCtD
Gatifloxacin—Tinnitus—Doxorubicin—uterine cancer	0.000787	0.000787	CcSEcCtD
Gatifloxacin—Flatulence—Epirubicin—uterine cancer	0.000783	0.000783	CcSEcCtD
Gatifloxacin—Tension—Epirubicin—uterine cancer	0.000779	0.000779	CcSEcCtD
Gatifloxacin—Dysgeusia—Epirubicin—uterine cancer	0.000778	0.000778	CcSEcCtD
Gatifloxacin—Nervousness—Epirubicin—uterine cancer	0.000771	0.000771	CcSEcCtD
Gatifloxacin—Back pain—Epirubicin—uterine cancer	0.000768	0.000768	CcSEcCtD
Gatifloxacin—Dizziness—Etoposide—uterine cancer	0.000765	0.000765	CcSEcCtD
Gatifloxacin—Muscle spasms—Epirubicin—uterine cancer	0.000764	0.000764	CcSEcCtD
Gatifloxacin—Chills—Doxorubicin—uterine cancer	0.000757	0.000757	CcSEcCtD
Gatifloxacin—Vision blurred—Epirubicin—uterine cancer	0.000748	0.000748	CcSEcCtD
Gatifloxacin—Vomiting—Etoposide—uterine cancer	0.000735	0.000735	CcSEcCtD
Gatifloxacin—Erythema—Doxorubicin—uterine cancer	0.000735	0.000735	CcSEcCtD
Gatifloxacin—Agitation—Epirubicin—uterine cancer	0.00073	0.00073	CcSEcCtD
Gatifloxacin—Rash—Etoposide—uterine cancer	0.000729	0.000729	CcSEcCtD
Gatifloxacin—Dermatitis—Etoposide—uterine cancer	0.000728	0.000728	CcSEcCtD
Gatifloxacin—Headache—Etoposide—uterine cancer	0.000724	0.000724	CcSEcCtD
Gatifloxacin—Flatulence—Doxorubicin—uterine cancer	0.000724	0.000724	CcSEcCtD
Gatifloxacin—Tension—Doxorubicin—uterine cancer	0.000721	0.000721	CcSEcCtD
Gatifloxacin—Dysgeusia—Doxorubicin—uterine cancer	0.00072	0.00072	CcSEcCtD
Gatifloxacin—Nervousness—Doxorubicin—uterine cancer	0.000714	0.000714	CcSEcCtD
Gatifloxacin—Vertigo—Epirubicin—uterine cancer	0.000714	0.000714	CcSEcCtD
Gatifloxacin—Syncope—Epirubicin—uterine cancer	0.000712	0.000712	CcSEcCtD
Gatifloxacin—Back pain—Doxorubicin—uterine cancer	0.000711	0.000711	CcSEcCtD
Gatifloxacin—Muscle spasms—Doxorubicin—uterine cancer	0.000706	0.000706	CcSEcCtD
Gatifloxacin—Palpitations—Epirubicin—uterine cancer	0.000702	0.000702	CcSEcCtD
Gatifloxacin—Loss of consciousness—Epirubicin—uterine cancer	0.000698	0.000698	CcSEcCtD
Gatifloxacin—Vision blurred—Doxorubicin—uterine cancer	0.000693	0.000693	CcSEcCtD
Gatifloxacin—Convulsion—Epirubicin—uterine cancer	0.000688	0.000688	CcSEcCtD
Gatifloxacin—Nausea—Etoposide—uterine cancer	0.000687	0.000687	CcSEcCtD
Gatifloxacin—Hypertension—Epirubicin—uterine cancer	0.000686	0.000686	CcSEcCtD
Gatifloxacin—Arthralgia—Epirubicin—uterine cancer	0.000676	0.000676	CcSEcCtD
Gatifloxacin—Chest pain—Epirubicin—uterine cancer	0.000676	0.000676	CcSEcCtD
Gatifloxacin—Myalgia—Epirubicin—uterine cancer	0.000676	0.000676	CcSEcCtD
Gatifloxacin—Agitation—Doxorubicin—uterine cancer	0.000675	0.000675	CcSEcCtD
Gatifloxacin—Anxiety—Epirubicin—uterine cancer	0.000674	0.000674	CcSEcCtD
Gatifloxacin—Vertigo—Doxorubicin—uterine cancer	0.00066	0.00066	CcSEcCtD
Gatifloxacin—Syncope—Doxorubicin—uterine cancer	0.000659	0.000659	CcSEcCtD
Gatifloxacin—Confusional state—Epirubicin—uterine cancer	0.000654	0.000654	CcSEcCtD
Gatifloxacin—Palpitations—Doxorubicin—uterine cancer	0.000649	0.000649	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Epirubicin—uterine cancer	0.000648	0.000648	CcSEcCtD
Gatifloxacin—Oedema—Epirubicin—uterine cancer	0.000648	0.000648	CcSEcCtD
Gatifloxacin—Loss of consciousness—Doxorubicin—uterine cancer	0.000646	0.000646	CcSEcCtD
Gatifloxacin—Infection—Epirubicin—uterine cancer	0.000644	0.000644	CcSEcCtD
Gatifloxacin—Shock—Epirubicin—uterine cancer	0.000638	0.000638	CcSEcCtD
Gatifloxacin—Convulsion—Doxorubicin—uterine cancer	0.000637	0.000637	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Epirubicin—uterine cancer	0.000635	0.000635	CcSEcCtD
Gatifloxacin—Hypertension—Doxorubicin—uterine cancer	0.000634	0.000634	CcSEcCtD
Gatifloxacin—Tachycardia—Epirubicin—uterine cancer	0.000633	0.000633	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Epirubicin—uterine cancer	0.000627	0.000627	CcSEcCtD
Gatifloxacin—Myalgia—Doxorubicin—uterine cancer	0.000626	0.000626	CcSEcCtD
Gatifloxacin—Arthralgia—Doxorubicin—uterine cancer	0.000626	0.000626	CcSEcCtD
Gatifloxacin—Chest pain—Doxorubicin—uterine cancer	0.000626	0.000626	CcSEcCtD
Gatifloxacin—Anxiety—Doxorubicin—uterine cancer	0.000623	0.000623	CcSEcCtD
Gatifloxacin—Anorexia—Epirubicin—uterine cancer	0.000618	0.000618	CcSEcCtD
Gatifloxacin—Hypotension—Epirubicin—uterine cancer	0.000606	0.000606	CcSEcCtD
Gatifloxacin—Confusional state—Doxorubicin—uterine cancer	0.000605	0.000605	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Doxorubicin—uterine cancer	0.0006	0.0006	CcSEcCtD
Gatifloxacin—Oedema—Doxorubicin—uterine cancer	0.0006	0.0006	CcSEcCtD
Gatifloxacin—Infection—Doxorubicin—uterine cancer	0.000596	0.000596	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000591	0.000591	CcSEcCtD
Gatifloxacin—Shock—Doxorubicin—uterine cancer	0.00059	0.00059	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Doxorubicin—uterine cancer	0.000587	0.000587	CcSEcCtD
Gatifloxacin—Insomnia—Epirubicin—uterine cancer	0.000586	0.000586	CcSEcCtD
Gatifloxacin—Tachycardia—Doxorubicin—uterine cancer	0.000585	0.000585	CcSEcCtD
Gatifloxacin—Paraesthesia—Epirubicin—uterine cancer	0.000582	0.000582	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Doxorubicin—uterine cancer	0.00058	0.00058	CcSEcCtD
Gatifloxacin—Dyspnoea—Epirubicin—uterine cancer	0.000578	0.000578	CcSEcCtD
Gatifloxacin—Somnolence—Epirubicin—uterine cancer	0.000576	0.000576	CcSEcCtD
Gatifloxacin—Anorexia—Doxorubicin—uterine cancer	0.000572	0.000572	CcSEcCtD
Gatifloxacin—Dyspepsia—Epirubicin—uterine cancer	0.000571	0.000571	CcSEcCtD
Gatifloxacin—Decreased appetite—Epirubicin—uterine cancer	0.000563	0.000563	CcSEcCtD
Gatifloxacin—Hypotension—Doxorubicin—uterine cancer	0.00056	0.00056	CcSEcCtD
Gatifloxacin—Constipation—Epirubicin—uterine cancer	0.000554	0.000554	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000546	0.000546	CcSEcCtD
Gatifloxacin—Insomnia—Doxorubicin—uterine cancer	0.000542	0.000542	CcSEcCtD
Gatifloxacin—Paraesthesia—Doxorubicin—uterine cancer	0.000539	0.000539	CcSEcCtD
Gatifloxacin—Dyspnoea—Doxorubicin—uterine cancer	0.000535	0.000535	CcSEcCtD
Gatifloxacin—Feeling abnormal—Epirubicin—uterine cancer	0.000534	0.000534	CcSEcCtD
Gatifloxacin—Somnolence—Doxorubicin—uterine cancer	0.000533	0.000533	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Epirubicin—uterine cancer	0.00053	0.00053	CcSEcCtD
Gatifloxacin—Dyspepsia—Doxorubicin—uterine cancer	0.000528	0.000528	CcSEcCtD
Gatifloxacin—Decreased appetite—Doxorubicin—uterine cancer	0.000521	0.000521	CcSEcCtD
Gatifloxacin—Urticaria—Epirubicin—uterine cancer	0.000515	0.000515	CcSEcCtD
Gatifloxacin—Constipation—Doxorubicin—uterine cancer	0.000513	0.000513	CcSEcCtD
Gatifloxacin—Abdominal pain—Epirubicin—uterine cancer	0.000512	0.000512	CcSEcCtD
Gatifloxacin—Body temperature increased—Epirubicin—uterine cancer	0.000512	0.000512	CcSEcCtD
Gatifloxacin—Feeling abnormal—Doxorubicin—uterine cancer	0.000494	0.000494	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.00049	0.00049	CcSEcCtD
Gatifloxacin—Hypersensitivity—Epirubicin—uterine cancer	0.000478	0.000478	CcSEcCtD
Gatifloxacin—Urticaria—Doxorubicin—uterine cancer	0.000476	0.000476	CcSEcCtD
Gatifloxacin—Body temperature increased—Doxorubicin—uterine cancer	0.000474	0.000474	CcSEcCtD
Gatifloxacin—Abdominal pain—Doxorubicin—uterine cancer	0.000474	0.000474	CcSEcCtD
Gatifloxacin—Asthenia—Epirubicin—uterine cancer	0.000465	0.000465	CcSEcCtD
Gatifloxacin—Pruritus—Epirubicin—uterine cancer	0.000459	0.000459	CcSEcCtD
Gatifloxacin—Diarrhoea—Epirubicin—uterine cancer	0.000443	0.000443	CcSEcCtD
Gatifloxacin—Hypersensitivity—Doxorubicin—uterine cancer	0.000442	0.000442	CcSEcCtD
Gatifloxacin—Asthenia—Doxorubicin—uterine cancer	0.00043	0.00043	CcSEcCtD
Gatifloxacin—Dizziness—Epirubicin—uterine cancer	0.000429	0.000429	CcSEcCtD
Gatifloxacin—Pruritus—Doxorubicin—uterine cancer	0.000424	0.000424	CcSEcCtD
Gatifloxacin—Vomiting—Epirubicin—uterine cancer	0.000412	0.000412	CcSEcCtD
Gatifloxacin—Diarrhoea—Doxorubicin—uterine cancer	0.00041	0.00041	CcSEcCtD
Gatifloxacin—Rash—Epirubicin—uterine cancer	0.000409	0.000409	CcSEcCtD
Gatifloxacin—Dermatitis—Epirubicin—uterine cancer	0.000408	0.000408	CcSEcCtD
Gatifloxacin—Headache—Epirubicin—uterine cancer	0.000406	0.000406	CcSEcCtD
Gatifloxacin—Dizziness—Doxorubicin—uterine cancer	0.000397	0.000397	CcSEcCtD
Gatifloxacin—Nausea—Epirubicin—uterine cancer	0.000385	0.000385	CcSEcCtD
Gatifloxacin—Vomiting—Doxorubicin—uterine cancer	0.000381	0.000381	CcSEcCtD
Gatifloxacin—Rash—Doxorubicin—uterine cancer	0.000378	0.000378	CcSEcCtD
Gatifloxacin—Dermatitis—Doxorubicin—uterine cancer	0.000378	0.000378	CcSEcCtD
Gatifloxacin—Headache—Doxorubicin—uterine cancer	0.000376	0.000376	CcSEcCtD
Gatifloxacin—Nausea—Doxorubicin—uterine cancer	0.000356	0.000356	CcSEcCtD
